Simonneau G, Montani D, Celermajer DS, Denton CP, Gatzoulis MA, Krowka M, Williams PG, Souza R (2019) Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur Respir J 53

Galiè N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, Simonneau G, Peacock A, Vonk Noordegraaf A, Beghetti M, Ghofrani A, Gomez Sanchez MA, Hansmann G, Klepetko W, Lancellotti P, Matucci M, McDonagh T, Pierard LA, Trindade PT, Zompatori M, Hoeper M (2016) 2015 ESC/ERS Guidelines for the Diagnosis and Treatment of Pulmonary Hypertension. Revista espanola de cardiologia (English ed) 69:177

Humbert M, Kovacs G, Hoeper MM, Badagliacca R, Berger RMF, Brida M, Carlsen J, Coats AJS, Escribano-Subias P, Ferrari P, Ferreira DS, Ghofrani HA, Giannakoulas G, Kiely DG, Mayer E, Meszaros G, Nagavci B, Olsson KM, Pepke-Zaba J, Quint JK, Rådegran G, Simonneau G, Sitbon O, Tonia T, Toshner M, Vachiery JL, Vonk Noordegraaf A, Delcroix M, Rosenkranz S (2022) 2022 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J 43:3618–3731

Article  CAS  PubMed  Google Scholar 

Newnham M, Bunclark K, Abraham N, Ali S, Amaral-Almeida L, Cannon JE, Doughty N, Ng C, Ponnaberanam A, Sheares K, Speed N, Taboada D, Toshner M, Tsui S, Jenkins DP, Pepke-Zaba J (2020) CAMPHOR score: patient-reported outcomes are improved by pulmonary endarterectomy in chronic thromboembolic pulmonary hypertension. Eur Respir J 56

Ogawa A, Satoh T, Fukuda T, Sugimura K, Fukumoto Y, Emoto N, Yamada N, Yao A, Ando M, Ogino H, Tanabe N, Tsujino I, Hanaoka M, Minatoya K, Ito H, Matsubara H (2017) Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension: results of a Multicenter Registry. Circulation Cardiovasc Qual Outcomes 10

Aoki T, Sugimura K, Tatebe S, Miura M, Yamamoto S, Yaoita N, Suzuki H, Sato H, Kozu K, Konno R, Miyata S, Nochioka K, Satoh K, Shimokawa H (2017) Comprehensive evaluation of the effectiveness and safety of balloon pulmonary angioplasty for inoperable chronic thrombo-embolic pulmonary hypertension: long-term effects and procedure-related complications. Eur Heart J 38:3152–3159

Article  PubMed  Google Scholar 

Tanabe N, Ogo T, Hatano M, Kigawa A, Sunaya T, Sato S (2020) Safety and effectiveness of riociguat for chronic thromboembolic pulmonary hypertension in real-world clinical practice: interim data from post-marketing surveillance in Japan. Pulmonary Circulation 10:2045894020938986

Article  PubMed  PubMed Central  Google Scholar 

Delcroix M, Lang I, Pepke-Zaba J, Jansa P, D’Armini AM, Snijder R, Bresser P, Torbicki A, Mellemkjaer S, Lewczuk J, Simkova I, Barberà JA, de Perrot M, Hoeper MM, Gaine S, Speich R, Gomez-Sanchez MA, Kovacs G, Jaïs X, Ambroz D, Treacy C, Morsolini M, Jenkins D, Lindner J, Dartevelle P, Mayer E, Simonneau G (2016) Long-term outcome of patients with chronic thromboembolic pulmonary hypertension: results from an international prospective Registry. Circulation 133:859–871

Article  CAS  PubMed  Google Scholar 

Pepke-Zaba J, Jansa P, Kim NH, Naeije R, Simonneau G (2013) Chronic thromboembolic pulmonary hypertension: role of medical therapy. Eur Respir J 41:985–990

Article  CAS  PubMed  Google Scholar 

Joglar JA, Chung MK, Armbruster AL, Benjamin EJ, Chyou JY, Cronin EM, Deswal A, Eckhardt LL, Goldberger ZD, Gopinathannair R, Gorenek B, Hess PL, Hlatky M, Hogan G, Ibeh C, Indik JH, Kido K, Kusumoto F, Link MS, Linta KT, Marcus GM, McCarthy PM, Patel N, Patton KK, Perez MV, Piccini JP, Russo AM, Sanders P, Streur MM, Thomas KL, Times S, Tisdale JE, Valente AM, Van Wagoner DR (2023) 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and management of Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice guidelines. Circulation

Ortel TL, Neumann I, Ageno W, Beyth R, Clark NP, Cuker A, Hutten BA, Jaff MR, Manja V, Schulman S, Thurston C, Vedantham S, Verhamme P, Witt DM, Izcovich IDF, Nieuwlaat A, Ross R, Wiercioch SHJS, Zhang W Y and, Zhang Y (2020) American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism. Blood Adv 4:4693–4738

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bunclark K, Newnham M, Chiu YD, Ruggiero A, Villar SS, Cannon JE, Coghlan G, Corris PA, Howard L, Jenkins D, Johnson M, Kiely DG, Ng C, Screaton N, Sheares K, Taboada D, Tsui S, Wort SJ, Pepke-Zaba J (2020) Toshner M. A multicenter study of anticoagulation in operable chronic thromboembolic pulmonary hypertension. J Thromb Haemostasis: JTH 18:114–122

Article  CAS  Google Scholar 

Jeong I, Alotaibi M, Fernandes TM, Kim S, Kerr KM, Yang J, Pretorius V, Madani M, Kim NH (2022) Direct oral anticoagulants in patients with chronic thromboembolic pulmonary hypertension and the presence of recent thrombus during pulmonary endarterectomy. Pulmonary Circulation 12:e12110

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hosokawa K, Watanabe H, Taniguchi Y, Ikeda N, Inami T, Yasuda S, Murohara T, Hatano M, Tamura Y, Yamashita J, Tatsumi K, Tsujino I, Kobayakawa Y, Adachi S, Yaoita N, Minatsuki S, Todaka K, Fukuda K, Tsutsui H, Abe KA, Multicenter (2023) Single-Blind, randomized, warfarin-controlled trial of Edoxaban in patients with chronic Thromboembolic Pulmonary Hypertension: KABUKI Trial. Circulation

Sterne JAC, Savović J, Page MJ, Elbers RG, Blencowe NS, Boutron I, Cates CJ, Cheng HY, Corbett MS, Eldridge SM, Emberson JR, Hernán MA, Hopewell S, Hróbjartsson A, Junqueira DR, Jüni P, Kirkham JJ, Lasserson T, Li T, McAleenan A, Reeves BC, Shepperd S, Shrier I, Stewart LA, Tilling K, White IR, Whiting PF, Higgins JPT (2019) RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ (Clinical Res ed) 366:l4898

Google Scholar 

A WG, B S and D OC. The Newcastle Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. (2014) http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp. Accessed by November 30, 2023

Zhu W, Wu Z, Dong Y, Lip GYH, Liu C (2022) Effectiveness of early rhythm control in improving clinical outcomes in patients with atrial fibrillation: a systematic review and meta-analysis. BMC Med 20:340

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhu W, Ye Z, Chen S, Wu D, He J, Dong Y, Lip GYH, Liu C (2021) Comparative effectiveness and safety of Non-vitamin K antagonist oral anticoagulants in Atrial Fibrillation patients. Stroke 52:1225–1233

Article  CAS  PubMed  Google Scholar 

Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539–1558

Article  PubMed  Google Scholar 

Hosokawa K, Abe K, Tsutsui H (2019) Use of direct oral anticoagulants prevents increase in pulmonary vascular resistance and incidence of clinical worsening in patients with chronic thromboembolic pulmonary hypertension. Thromb Res 180:43–46

Article  CAS  PubMed  Google Scholar 

Sena S, Bulent M, Derya K, Deniz K, Halil A, Okan E, Bedrettin Y (2020) Real-life data of direct anticoagulant use, bleeding risk and venous thromboembolism recurrence in chronic thromboembolic pulmonary hypertension patients: an observational retrospective study. Pulmonary Circulation 10:2045894019873545

Article  PubMed  PubMed Central  Google Scholar 

Ikeda N, Amemiya K, Sato S, Iijima R, Hara H, Nakamura M (2021) Evolution of patients with chronic thromboembolic pulmonary hypertension treated by balloon pulmonary angioplasty, according to their anticoagulant regimens. Heart Vessels 36:910–915

Article  PubMed  Google Scholar 

Zhu YJ, Zhou YP, Wei YP, Xu XQ, Yan XX, Liu C, Zhu XJ, Liu ZY, Sun K, Hua L, Jiang X, Jing ZC (2021) Association between anticoagulation outcomes and venous thromboembolism history in Chronic Thromboembolic Pulmonary Hypertension. Front Cardiovasc Med 8:628284

Article  CAS  PubMed  PubMed Central  Google Scholar 

Humbert M, Simonneau G, Pittrow D, Delcroix M, Pepke-Zaba J, Langleben D, Mielniczuk LM, Escribano Subias P, Snijder RJ, Barberà JA, Klotsche J, Meier C, Hoeper MM (2022) Oral anticoagulants (NOAC and VKA) in chronic thromboembolic pulmonary hypertension. J Heart lung Transplantation: Official Publication Int Soc Heart Transplantation 41:716–721

Article  Google Scholar 

Barati S, Amini H, Ahmadi ZH, Dastan A, Sharif Kashani B, Eskandari R, Dastan F (2023) Evaluating the efficacy and safety of rivaroxaban as a warfarin alternative in chronic thromboembolic pulmonary hypertension patients undergoing pulmonary endarterectomy: a randomized clinical trial. Revista Portuguesa De Cardiologia: orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese J Cardiol: Official J Portuguese Soc Cardiol 42:139–144

Google Scholar 

Benzidia I, Robitaille C, Abualsaud A, McDonald L, Lesenko L, Morin JF, Langleben D, Kahn SR, Hirsch A (2023) Safety and efficacy of direct oral anticoagulants in patients with chronic thromboembolic pulmonary hypertension. Thromb Res 229:139–145

Article  CAS  PubMed  Google Scholar 

Hosokawa K, Abe K, Funakoshi K, Tamura Y, Nakashima N, Todaka K, Taniguchi Y, Inami T, Adachi S, Tsujino I, Yamashita J, Minatsuki S, Ikeda N, Shimokawahara H, Kawakami T, Ogo T, Hatano M, Ogino H, Fukumoto Y, Tanabe N, Matsubara H, Fukuda K, Tatsumi K, Tsutsui H (2023) Long-term outcome of chronic thromboembolic pulmonary hypertension using direct oral anticoagulants and warfarin: a Japanese prospective cohort study. J Thromb Haemostasis: JTH 21:2151–2162

Article  Google Scholar 

Sedhom R, Megaly M, Gupta E, Amanullah A (2022) Use of direct oral anticoagulants in chronic thromboembolic pulmonary hypertension: a systematic review. J Thromb Thrombolysis 53:51–57

Article  PubMed  Google Scholar 

Ishisaka Y, Watanabe A, Takagi H, Steiger D, Kuno T (2023) Anticoagulation in chronic thromboembolic pulmonary hypertension: a systematic review and meta-analysis. Thromb Res 231:91–98

Article  CAS  PubMed  Google Scholar 

Pengo V, Denas G, Zoppellaro G, Jose SP, Hoxha A, Ruffatti A, Andreoli L, Tincani A, Cenci C, Prisco D, Fierro T, Gresele P, Cafolla A, De Micheli V, Ghirarduzzi A, Tosetto A, Falanga A, Martinelli I, Testa S, Barcellona D, Gerosa M, Banzato A (2018) Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome. Blood 132:1365–1371

Article  CAS  PubMed  Google Scholar 

Koval N, Alves M, Plácido R, Almeida AG, Fonseca JE, Ferreira JJ, Pinto FJ, Caldeira D (2021) Direct oral anticoagulants versus vitamin K antagonists in patients with antiphospholipid syndrome: systematic review and meta-analysis. RMD open 7

Karia N, Howard L, Johnson M, Kiely DG, Lordan J, McCabe C, Pepke-Zaba J, Ong R, Preiss M, Knight D, Muthurangu V, Coghlan JG (2023) Predictors of outcomes in mild pulmonary hypertension according to 2022 ESC/ERS guidelines: the EVIDENCE-PAH UK study. Eur Heart J 44:4678–4691

Article  PubMed  PubMed Central  Google Scholar